Cps Locator 3d Delivery Catheter
Centerpoint Systems
FDA Clearance Information
The CPS Locator 3D Delivery Catheter received FDA 510k clearance on March 9, 2023. Manufactured by Centerpoint Systems, it is classified as a Class 2 device under product code DQY.
What It Is
FDA-Cleared Indications
- A percutaneous catheter intended to facilitate the delivery or positioning of a pacing lead during a cardiac pacing procedure.
- Use in conduction system pacing procedures, when the treating physician determines that catheter-based lead delivery is appropriate.
Clinical Applications
- Delivery and positioning of pacing leads during conduction system pacing.
- Catheter-assisted access to the region targeted for cardiac pacing lead placement.
- Use during procedures for patients who require permanent cardiac pacing, when the device is selected by the treating physician.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The supplied FDA record does not list catheter dimensions, working length, curve options, guidewire compatibility, or other sizing details; these should be confirmed in the current manufacturer instructions for use.
- The catheter is used with compatible pacing leads and other accessories specified by the manufacturer. Compatibility should be verified before the procedure.
- Use requires fluoroscopic or other appropriate cardiac imaging guidance and an operator familiar with transvenous pacing procedures.
- MRI status applies primarily to the complete implanted pacing system, including the lead and pulse generator, rather than to the delivery catheter after the procedure. Check the labeling for the specific implanted system.
- Potential risks include vascular or cardiac injury, bleeding, infection, arrhythmia, lead dislodgement, and complications related to cardiac device implantation. Patient-specific contraindications and precautions are described in the manufacturer labeling.
Frequently Asked Questions
What are the clinical indications for CPS Locator 3D Delivery Catheter?
The device is indicated for use in conduction system pacing, particularly in left bundle branch area pacing.
What outcomes have been reported in clinical studies?
Studies have reported successful lead placement and favorable procedural outcomes with the use of stylet-driven leads.
What complications have been reported?
Reported complications include general procedural risks, but specific adverse events are not detailed in the studies provided.